Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity
after allogeneic stem cell transplantation. Though perfect response rates are not achieved …

Acute and chronic graft-versus-host disease (GVHD) remain major obstacles for successful
allogeneic hematopoietic cell transplantation. Extracorporeal photopheresis (ECP) …

Chronic graft-versus-host disease (GVHD) is a major limitation of successful allogeneic
hematopoietic stem cell transplantation (HSCT). Extracorporeal photochemotherapy (ECP) …

Graft-vs-host disease (GVHD) is a serious complication after allogeneic hematopoietic stem
cell transplantation causing significant morbidity and transplant-associated mortality. Acute …

Extracorporeal photopheresis (ECP) is an established treatment strategy in steroid-refractory
graft-versus-host disease (GVHD). This study's main objective was to analyze the clinical …

Although significant advances have been made in the biologic understanding of graft-versus-
host disease (GVHD) and its treatment options, GVHD remains the single most challenging …

Extracorporeal photopheresis (ECP) is a therapy that combines the collection of
mononuclear cells by apheresis, the addition of a photosensitizer (8-methoxisoralen), the …

Background. Extracorporeal photopheresis (ECP) is increasingly used in the treatment of
acute and chronic graft versus host disease (aGVHD). It is recognized as an …

Abstract Background and Summary: Extracorporeal photopheresis (ECP) is a leukapheresis-
based procedure used in the therapy of acute and chronic graft-versus-host disease …

Abstract Extracorporeal photochemotherapy (ECP; photopheresis), an immunomodulatory
therapy developed for cutaneous T‐cell lymphoma, has shown promise in treating chronic …